ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of I<sub>Kr</sub>

ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of I<sub>Kr</sub>

ABT-333 (dasabuvir) is an antiviral agent used in hepatitis C treatment. The molecule, similarly to some inhibitors of hERG channels, responsible for the delayed rectifier potassium current (I<sub>Kr</sub>), contains the methanesulfonamide group. Reduced I<sub>Kr</sub> curren...

Full description

Saved in:
Bibliographic Details
Main Authors: Zsigmond Máté Kovács (Author), József Óvári (Author), Csaba Dienes (Author), János Magyar (Author), Tamás Bányász (Author), Péter P. Nánási (Author), Balázs Horváth (Author), Adam Feher (Author), Zoltan Varga (Author), Norbert Szentandrássy (Author)
Format: Book
Published: MDPI AG, 2023-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items